Popular Keywords
Anaplastic lymphoma kinase
Biological therapies
Biomarkers
Cancer
Chemoradiotherapy
Clinical trials
Aims
The Clinical Lung Cancer is an independent worldwide publisher that publishes disseminating high-quality research and scientific knowledge in the field of Lung Cancer. The journal covers a wide range of topics related to scientific research.
The journal welcomes original research articles, clinical studies, review articles, case reports, and perspectives that contribute to advancing knowledge and understanding in Lung Cancer. It also aims to foster collaboration and exchange of ideas among researchers, clinicians, and other professionals in the field.
Scope
Anaplastic lymphoma kinase
Biological therapies
Biomarkers
Cancer
Chemoradiotherapy
Clinical trials
Comparative effectiveness
Concurrent chemoradiotherapy
Diagnosis and imaging
Epidermal growth factor receptor
Immunotherapy
Lung cancer
Lymph node
Pharmacoeconomics
Progression-free survival
Radiation Pneumonitis
Radiotherapy
Risk and prevention
Squamous cell lung cancer
Surgical approaches
Systemic therapies
Molecular biology of disease
Molecular diagnostics
Multivariate analysis
Overall survival
Journal Info
- Journal Name: The Clinical Lung Cancer
- ISSN: 3064-6693
- DOI: 10.52338/tclc
- Short Name: Tclc
- Acceptance rate: 55%
- Volume: 7 (2024)
- Submission to acceptance: 25 days
- Acceptance to publication: 10 days
OUR PUBLICATION BENEFITS
- International Reach
- Peer Review
- Rapid Publication
- Open Access
- High Visibility